These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15857578)

  • 1. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
    Lodygin D; Hermeking H
    Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
    Lodygin D; Diebold J; Hermeking H
    Oncogene; 2004 Dec; 23(56):9034-41. PubMed ID: 15489902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of 14-3-3sigma in cancer.
    Lodygin D; Hermeking H
    Semin Cancer Biol; 2006 Jun; 16(3):214-24. PubMed ID: 16698281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3sigma is down-regulated in human prostate cancer.
    Urano T; Takahashi S; Suzuki T; Fujimura T; Fujita M; Kumagai J; Horie-Inoue K; Sasano H; Kitamura T; Ouchi Y; Inoue S
    Biochem Biophys Res Commun; 2004 Jul; 319(3):795-800. PubMed ID: 15184053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
    Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M
    Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.
    Osada H; Tatematsu Y; Yatabe Y; Nakagawa T; Konishi H; Harano T; Tezel E; Takada M; Takahashi T
    Oncogene; 2002 Apr; 21(15):2418-24. PubMed ID: 11948426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3 proteins--an update.
    Mhawech P
    Cell Res; 2005 Apr; 15(4):228-36. PubMed ID: 15857577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The roles of DNA methylation in human neoplasms].
    Yuan YF; Li JQ; Yang ZL; Wang JP
    Ai Zheng; 2002 Nov; 21(11):1267-77. PubMed ID: 12526230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of 14-3-3sigma by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front.
    Ide M; Nakajima T; Asao T; Kuwano H
    Cancer Lett; 2004 Apr; 207(2):241-9. PubMed ID: 15072834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma.
    Lodygin D; Yazdi AS; Sander CA; Herzinger T; Hermeking H
    Oncogene; 2003 Aug; 22(35):5519-24. PubMed ID: 12934112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.
    Kaneuchi M; Sasaki M; Tanaka Y; Shiina H; Verma M; Ebina Y; Nomura E; Yamamoto R; Sakuragi N; Dahiya R
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1156-62. PubMed ID: 15044106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers.
    Suzuki H; Itoh F; Toyota M; Kikuchi T; Kakiuchi H; Imai K
    Cancer Res; 2000 Aug; 60(16):4353-7. PubMed ID: 10969776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation patterns of the CDH1, RARB, and SFN genes in choroid plexus tumors.
    Losi-Guembarovski R; Kuasne H; Guembarovski AL; Rainho CA; Cólus IM
    Cancer Genet Cytogenet; 2007 Dec; 179(2):140-5. PubMed ID: 18036402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene silencing by DNA methylation in haematological malignancies.
    Boultwood J; Wainscoat JS
    Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic changes in cancer and preneoplasia.
    Herman JG
    Cold Spring Harb Symp Quant Biol; 2005; 70():329-33. PubMed ID: 16869769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [14-3-3sigma (stratifin), a potential tumor suppressor frequently inactivated by methylation in cancer of the breast].
    Jeanteur P
    Bull Cancer; 2000 Jul; 87(7-8):525. PubMed ID: 10969206
    [No Abstract]   [Full Text] [Related]  

  • 19. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma.
    Yi B; Tan SX; Tang CE; Huang WG; Cheng AL; Li C; Zhang PF; Li MY; Li JL; Yi H; Peng F; Chen ZC; Xiao ZQ
    J Cell Biochem; 2009 Apr; 106(5):858-66. PubMed ID: 19160382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.